These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 6782002

  • 1. IRI-secretion in MOD with and without SU (5 year control).
    Lohmann D, Verlohren HJ.
    Horm Metab Res; 1980 Dec; 12(12):702-3. PubMed ID: 6782002
    [No Abstract] [Full Text] [Related]

  • 2. [A new beta cell efficiency test in the islands of Langerhans].
    Páv J, Srámková J.
    Vnitr Lek; 1977 Jun; 23(7):639-46. PubMed ID: 331663
    [No Abstract] [Full Text] [Related]

  • 3. [Behavior of blood sugar and insulin in diabetics at the suspension of glibenclamide therapy].
    Pitucco G, Caputo V, Santucci A, Daniele E, De Mattia G, De Angelis A.
    Clin Ter; 1978 Jun 30; 85(6):550-8. PubMed ID: 97042
    [No Abstract] [Full Text] [Related]

  • 4. [Quantitative determination of C-peptide and insulin secretion for the evaluation of therapeutic action in manifest diabetes mellitus].
    Wölk I, Zilker T, Schweigart U, Ermler R, Paterek K, Bottermann P.
    Verh Dtsch Ges Inn Med; 1978 Jun 30; 83():1388-91. PubMed ID: 417495
    [No Abstract] [Full Text] [Related]

  • 5. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
    Happ J, Beyer J, Nest E, Fröhlich A, Althoff PH, Schöffling K.
    Arzneimittelforschung; 1974 Aug 30; 24(8):1228-34. PubMed ID: 4214173
    [No Abstract] [Full Text] [Related]

  • 6. Insulin secretion in maturity-onset-diabetes. Function of isolated islets.
    Lohmann D, Jahr H, Verlohren HJ, Schmidt S, Heilmann W, Zühlke H, Hartig W, Mättig H.
    Horm Metab Res; 1980 Aug 30; 12(8):349-53. PubMed ID: 6997161
    [Abstract] [Full Text] [Related]

  • 7. [The glibenclamide-phenformin combination in the therapy of diabetes mellitus].
    Polosa P, Mughini L.
    Minerva Med; 1974 Aug 29; 65(59):383-9. PubMed ID: 4213556
    [No Abstract] [Full Text] [Related]

  • 8. [Daily curves of blood sugar and serum insulin after treatment with various combinations of glibenclamide and phenformin].
    Giangrandi E, Scaroina F, Tommasini-Degna C.
    Minerva Med; 1975 Mar 14; 66(19):940-5. PubMed ID: 804684
    [No Abstract] [Full Text] [Related]

  • 9. Glucose, FFA, IRI and GH response to I.V. glibenclamide.
    Rastogi GK, Dash RJ, Sinha MK.
    Horm Metab Res; 1973 Jul 14; 5(4):303. PubMed ID: 4199903
    [No Abstract] [Full Text] [Related]

  • 10. [Various disturbances in beta cell function in diabetes mellitus].
    Lohmann D, Verlohren HJ, Ellorhaoui M.
    Endokrinologie; 1977 Jul 14; 69(2):239-45. PubMed ID: 334525
    [Abstract] [Full Text] [Related]

  • 11. Glibenclamide, acute/long-term response in M.O. diabetics.
    Owens DR, Wragg KG, Shetty KT, Biggs PI, Davies CD.
    Horm Metab Res; 1979 Jun 14; 11(6):411-2. PubMed ID: 112018
    [No Abstract] [Full Text] [Related]

  • 12. Clinical comparison between glipentide (Staticum) and glibenclamide in diabetics.
    Moncada Lorenzo E, Garcia RV, Barberia Layana JJ, Morant Ciscard JA, Calleja Canelas A.
    Curr Ther Res Clin Exp; 1977 Jan 14; 21(1):50-7. PubMed ID: 401712
    [No Abstract] [Full Text] [Related]

  • 13. [Controlled clinical study of the therapeutic action of 2 combinations of glibenclamide and phenformin].
    Mascetti P, Mascetti R, Sampietro M.
    Clin Ter; 1978 Aug 15; 86(3):263-75. PubMed ID: 105830
    [No Abstract] [Full Text] [Related]

  • 14. [Glibenclamide in type II diabetes as compared with placebo].
    Breier C, Lisch HJ, Drexel H, Sailer S.
    Wien Klin Wochenschr; 1983 Mar 18; 95(6):200-3. PubMed ID: 6410589
    [Abstract] [Full Text] [Related]

  • 15. Experience with glibenclamide.
    Rastogi GK, Dash RJ, Sinha SM.
    J Indian Med Assoc; 1973 Jul 01; 61(1):60-2. PubMed ID: 4202387
    [No Abstract] [Full Text] [Related]

  • 16. The clinical evaluation of an oral antidiabetic drug.
    Müller R.
    Aust N Z J Med; 1971 Aug 01; 1():Suppl 2:39-46. PubMed ID: 5005130
    [No Abstract] [Full Text] [Related]

  • 17. Acute suppressive effect of human growth hormone on insulin release induced by glucagon and tolbutamide in man.
    Adamson U, Cerasi E.
    Diabete Metab; 1975 Mar 01; 1():51-6. PubMed ID: 1234067
    [Abstract] [Full Text] [Related]

  • 18. [The importance of serum insulin determination in the diagnosis and treatment of diabetes mellitus (author's transl)].
    Willms B.
    MMW Munch Med Wochenschr; 1975 Oct 10; 117(41):1643-8. PubMed ID: 810689
    [Abstract] [Full Text] [Related]

  • 19. Pharmacological comparison between tolbutamide and two second generation hypoglycemic sulfonylureas (glibenclamide and glisoxepide).
    Loubatiéres A, Mariani MM, Ribes G, Alric R.
    Acta Diabetol Lat; 1973 Oct 10; 10(2):261-82. PubMed ID: 4200675
    [No Abstract] [Full Text] [Related]

  • 20. [A comparison of intravenous tolbutamide and insulin administration during and after operation in patients with maturity-onset diabetes (author's transl)].
    Fähndrich W, Liebermeister H, Schmitt H, Daweke H.
    Dtsch Med Wochenschr; 1974 Jan 25; 99(4):121-7. PubMed ID: 4203796
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.